What Is Immatics N.V. (IMTX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Immatics N.V.'s intrinsic value is estimated at $5.71. Trading at its current price of $9.47, the valuation engine raises significant caution: 10 of 12 models flag downside risk, projecting an average implied return of -39.7%. Notably, First Chicago sees the most upside at +92.0% (fair value: $18.18), while ML-RIV is the most conservative at -91.1% ($0.84). The spread between these extremes — +183.1% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About IMTX?
12 of 13 models are currently active for IMTX. Of these, 2 models suggest upside while 10 models suggest overvaluation. The Bayesian DCF estimates IMTX's intrinsic value at $1.93, implying -79.7% downside from the current price. See which stocks rank higher →
How Does IMTX Rank in Biological Products, (No Diagnostic Substances)?
Among 134 Biological Products, (No Diagnostic Substances) stocks, IMTX ranks #51 by Quality of Company score. CirclFi's QOC score of 5.8/10 evaluates 32 fundamental signals. A score of 5.8 reflects mixed fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Immatics N.V. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is IMTX a Value Trap?
The Value Trap algorithm is not active for IMTX. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Immatics N.V.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Immatics N.V. earns a quality score of 5.8/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +183.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every IMTX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across IMTX's 12 active models, average confidence is 32%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad